TD Cowen cuts rating on Illumina stock to hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Barclays Downgrades Illumina (ILMN) to Underweight
February 10, 2025 6:13 AM ESTBarclays analyst Luke Sergott downgraded Illumina (NASDAQ: ILMN) from Equalweight to Underweight with a price target of $100.00 (from $130.00).
The analyst comments "Overall, we view ILMN as a great business with a technological edge that has matured along with the market it created. We think that it is a normal Tools business not unlike other mature genomics / proteomics markets like PCR and mass spec. These are solid MSD topline growers with an oligopoly... More
